Does Jim Cramer recommend buying ISRG stock?

No, he did not recommend buying; instead, he warned about intense competition that could negatively impact the stock's performance.

Which companies compete with Intuitive Surgical?

Key competitors include Medtronic and Johnson & Johnson, which are launching their own robotic surgery systems.

How does competition affect Intuitive Surgical?

Competition could erode its market share and profit margins, weakening its competitive position.

Jim Cramer: Intuitive Surgical Faces 'Too Much Competition'

Jim Cramer stated that Intuitive Surgical is facing too much competition, threatening its once-dominant position in robotic surgery, during a caller Q&A on his show.

June 23, 2026

2 min read

Source: Insider Monkey

On a recent episode of Mad Money, Jim Cramer addressed a caller's question about Intuitive Surgical (NASDAQ:ISRG), responding bluntly: "Too much competition, too much competition… Used to be king, but now there's a lot of competition."

Details of the Statement

Cramer highlighted that Intuitive Surgical had long monopolized the robotic surgery market, but now faces increasing competitive pressure from companies like Medtronic and Johnson & Johnson (NYSE:JNJ), which are launching their own robotic surgery systems. He added that this competition could erode Intuitive's market share and profit margins.

Context

Cramer's comments came during a broader discussion about the potential impact of Iran peace negotiations on oil markets, inflation, and interest rates. While lower interest rates could benefit growth stocks like Intuitive Surgical, Cramer believes competitive challenges outweigh this positive factor.

What It Means for Investors

Cramer's remarks reflect growing market concern about Intuitive Surgical's ability to maintain its leadership amid strong new entrants. Investors should monitor the company's market share trends and future innovations to assess the competitive impact on its performance.

Frequently Asked Questions

Jim Cramer said the stock faces intense competition that threatens its dominant position, noting that companies like Medtronic and Johnson & Johnson are entering the market strongly.

Found this useful? Share it

This article was rewritten in Wrqti's editorial style based on information from the original source above. Content is informational only — not investment advice.